Pancreatic Cancer Research

ResearcherBiomedical Research Center of the Slovak Academy of SciencesActive in the last 2 years

Božena Smolková

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4906-5652; OpenAlex author ID A5076197399. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
43
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 3 papers · 2024: none · 2025: 4 papers · 2026: 1 paper

Papers 11

  1. Epigenetic modulation to overcome immune suppression in pancreatic cancer. Last author DOI 10.1186/s13148-026-02081-5↗
  2. Placental mesenchymal stem cells: A promising platform for advancing gene therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.biopha.2025.118428↗
  3. Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. Last author DOI 10.1016/j.semcancer.2025.01.003↗
  4. Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer. Co-author DOI 10.1016/j.semcancer.2025.05.005↗
  5. Combined action of suicide gene exosomes from pancreatic cancer-associated fibroblasts and from mesenchymal stem cells as a pancreatic ductal adenocarcinoma tr… Co-author DOI 10.1186/s12935-025-04130-0↗
  6. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival. Co-author DOI 10.1016/j.biopha.2023.115179↗
  7. Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review. Co-author DOI 10.3390/biology12020158↗
  8. Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue. Co-author DOI 10.3791/65229↗
  9. DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Last author DOI 10.3390/ijms23042117↗
  10. Bratislava Statement: consensus recommendations for improving pancreatic cancer care. Co-author DOI 10.1136/esmoopen-2020-001051↗
  11. Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance? Last author DOI 10.3390/ijms21114091↗

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Verona Buociková · 7 shared papers, 2022–2026 · strength 1.29
  2. Maria Urbanova · 6 shared papers, 2022–2025 · strength 0.98
  3. Julie Earl · 5 shared papers, 2020–2025 · strength 0.74
  4. Michal Mego · 2 shared papers, 2025–2026 · strength 0.49
  5. Laura Drndakova · 2 shared papers, 2025–2026 · strength 0.49
  6. Daniele Campa · 2 shared papers, 2025 · strength 0.41
  7. Č Altaner · 2 shared papers, 2025 · strength 0.37
  8. Jana Jakubechova · 2 shared papers, 2025 · strength 0.37
  9. Alfredo Carrato · 3 shared papers, 2020–2023 · strength 0.35
  10. Bruno Sáinz · 2 shared papers, 2023 · strength 0.28
  11. Soňa Čierniková · 2 shared papers, 2020–2022 · strength 0.27
  12. Ľuba Hunáková · 1 shared paper, 2023 · strength 0.26
  13. Iveta Mikolášková · 1 shared paper, 2023 · strength 0.26
  14. Tatjana Crnogorac‐Jurcevic · 1 shared paper, 2023 · strength 0.26
  15. Kari Hemminki · 1 shared paper, 2025 · strength 0.22
  16. Saba Selvi · 1 shared paper, 2025 · strength 0.22
  17. Ľudmila Vodičková · 1 shared paper, 2025 · strength 0.22
  18. Pavel Vodička · 1 shared paper, 2025 · strength 0.22
  19. Erika Halášová · 1 shared paper, 2025 · strength 0.22
  20. Manuel Gentiluomo · 1 shared paper, 2025 · strength 0.22
  21. Cosmeri Rizzato · 1 shared paper, 2025 · strength 0.22
  22. Chiara Corradi · 1 shared paper, 2025 · strength 0.19
  23. Jörg Tost · 1 shared paper, 2025 · strength 0.19
  24. Seçil Ak Aksoy · 1 shared paper, 2025 · strength 0.19
  25. Riccardo Farinella · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.